Published in Int Urogynecol J Pelvic Floor Dysfunct on November 25, 2003
Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial. BMC Womens Health (2011) 0.86
Tension-free vaginal tape versus lata fascia sling: The importance of transvulvar ultrasound in the assessment of relevant anatomical parameters in treatment of women with stress urinary incontinence. Indian J Urol (2009) 0.75
Multimodal vaginal toning for bladder symptoms and quality of life in stress urinary incontinence. Int Urogynecol J (2016) 0.75
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 22.80
Estimating log models: to transform or not to transform? J Health Econ (2001) 11.10
Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev (1987) 10.58
Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol (1996) 4.03
Annual direct cost of urinary incontinence. Obstet Gynecol (2001) 3.35
Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol (1991) 2.49
Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol (2002) 2.43
The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc (1991) 2.38
Definition of overactive bladder and epidemiology of urinary incontinence. Urology (1997) 2.14
The influence of urinary incontinence on the quality of life of elderly women. Age Ageing (1993) 2.07
Economic costs of urinary incontinence in 1995. Urology (1998) 1.85
Barriers to help seeking in people with urinary symptoms. Fam Pract (2001) 1.81
Quality of life and seeking help in women with urinary incontinence. Acta Obstet Gynecol Scand (2001) 1.81
Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev (2002) 1.60
Urinary incontinence and psychological distress in community-dwelling older adults. J Am Geriatr Soc (2002) 1.38
Economic considerations and outcome measurement in urge incontinence. Urology (1997) 1.17
Informal caregiving time and costs for urinary incontinence in older individuals in the United States. J Am Geriatr Soc (2002) 0.86
Impact of urinary incontinence on health-care costs. J Am Geriatr Soc (1990) 0.86
Cost-effectiveness of new treatments for overactive bladder: the example of tolterodine, a new muscarinic agent: a Markov model. Neurourol Urodyn (1998) 0.85
Costs and resources associated with the treatment of overactive bladder using retrospective medical care claims data. Manag Care Interface (2001) 0.75
Findings of a three-year retrospective study to investigate prevalence and incidence of urinary incontinence and overactive bladder in a typical managed care setting. Pharm Pract Manag Q (2000) 0.75
Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol (2011) 2.74
The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol (2004) 2.34
Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. J Manag Care Pharm (2004) 1.97
The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomes. J Rheumatol (2007) 1.95
Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia. Pain Pract (2010) 1.57
American attitudes toward and willingness to use psychiatric medications. J Nerv Ment Dis (2003) 1.56
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56
Burden of illness in Parkinson's disease. Mov Disord (2005) 1.48
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res (2006) 1.17
Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol (2002) 1.17
The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep (2011) 1.16
Response, partial response, and nonresponse in primary care treatment of depression. Arch Intern Med (2004) 1.09
Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med (2005) 1.08
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). Neuropsychobiology (2007) 1.04
The cost consequences of treatment-resistant depression. J Clin Psychiatry (2004) 0.97
An electronic diary study of contextual triggers and ADHD: get ready, get set, get mad. J Am Acad Child Adolesc Psychiatry (2006) 0.97
Parental depression as a moderator of secondary deficits of depression in adult offspring. Child Psychiatry Hum Dev (2009) 0.96
Toward mapping daily challenges of living with ADHD: maternal and child perspectives using electronic diaries. J Abnorm Child Psychol (2006) 0.95
A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode. Int Clin Psychopharmacol (2012) 0.94
Healthcare utilization among women who undergo surgery for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.92
Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J Diabetes Complications (2008) 0.91
Comparative and interactive effects of depression relative to other health problems on work performance in the workforce of a large employer. J Occup Environ Med (2008) 0.90
Real-world role of tricyclic antidepressants in the treatment of fibromyalgia. Pain Pract (2012) 0.90
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Int Psychogeriatr (2005) 0.89
Q-TWiST analysis of ixabepilone in combination with capecitabine on quality of life in patients with metastatic breast cancer. Cancer (2011) 0.88
Premenstrual dysphoric disorder: is there an economic burden of illness? Med Care (2002) 0.87
The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder. J Nerv Ment Dis (2009) 0.87
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res (2008) 0.87
Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls. Curr Med Res Opin (2009) 0.83
ADHD and anger contexts: electronic diary mood reports from mothers and children. J Pediatr Psychol (2009) 0.82
A provisional screening instrument for four common mental disorders in adult primary care patients. Psychosomatics (2011) 0.82
Emotional expression in children treated with ADHD medication: development of a new measure. J Atten Disord (2008) 0.82
The impact of anaemia and its treatment on employee disability and medical costs. Pharmacoeconomics (2005) 0.82
Are men with erectile dysfunction more likely to have hypertension than men without erectile dysfunction? A naturalistic national cohort study. J Urol (2005) 0.81
The application of two health and productivity instruments at a large employer. J Occup Environ Med (2004) 0.80
The costs of caring for erectile dysfunction in a managed care setting: evidence from a large national claims database. J Urol (2005) 0.80
PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients. Postgrad Med (2011) 0.79
Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction. J Sex Med (2005) 0.78
Melding regulatory, pharmaceutical industry, and U.S. payer perspectives on improving approaches to heterogeneity of treatment effect in research and practice. Value Health (2013) 0.78
Impact of duloxetine on quality of life for women with symptoms of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.78
Atomoxetine versus stimulants in the community treatment of children with ADHD: an electronic diary study. J Atten Disord (2010) 0.78
Value-based assessment of pharmacodiagnostic testing from early stage development to real-world use. Value Health (2013) 0.77
The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy. Adv Ther (2013) 0.77
The direct and indirect costs among U.S. privately insured employees with hypogonadism. J Sex Med (2012) 0.77
Characteristics of depressed and nondepressed adult offspring of depressed and matched nondepressed parents. J Affect Disord (2008) 0.76
A retrospective study of patients' out-of-pocket costs for granulocyte colony-stimulating factors. J Oncol Pharm Pract (2013) 0.75
The direct cost of stress urinary incontinence among women in a Medicaid population. Am J Obstet Gynecol (2005) 0.75